Clinical Trial Update: Immune Response After Stem Cell Transplant in HIV-Positive Patients With Hematologic Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update examining immune response after stem cell transplant in HIV-positive patients with hematologic cancer; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hematologic Cancer

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Hematopoietic and Lymphoid Cell Neoplasm, HIV Infection | Phase 2 | Status: COMPLETED